COURTNEY DE SOUZA: Open Payments
NPI 1255957163 · BOLIVAR, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$874 in 48 payments from 14 companies in 2025. Trend: 2023 $196 · 2024 $577 · 2025 $874
Food & beverage: $874
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $185 |
| Novo Nordisk Inc | 7 | $118 |
| E.R. Squibb & Sons, L.L.C. | 6 | $110 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $101 |
| Lilly USA, LLC | 4 | $67 |
| Otsuka America Pharmaceutical, Inc. | 3 | $63 |
| Corium, LLC | 2 | $57 |
| AstraZeneca Pharmaceuticals LP | 3 | $54 |
| PFIZER INC. | 2 | $39 |
| Exact Sciences Corporation | 1 | $19 |
Products named: COBENFY, CAPLYTA, REXULTI, MAVYRET, Azstarys, VRAYLAR, BREZTRI, PREVNAR 20.
Industry payments across MO — which companies pay providers there.
